Microvascular injury and blood-brain barrier leakage in Alzheimer's disease

Neurobiology of Aging

Volumn 28, Issue 7, 2007, Pages 977-986

  Zipser, B D ^a   Johanson, C E ^a   Gonzalez, L ^c   Berzin, T M ^a   Tavares, R ^a   Hulette, C M ^b   Vitek, M P ^b   Hovanesian, V ^a   Stopa, E G ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c 3D Group for Interactive Visualization   (United States)

Author keywords

Agrin; Alzheimer's disease; APOE4; Blood brain barrier; Braak and Braak stage; ELISA; Prefrontal cortex; Prothrombin; Vascular basement membrane

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BLOOD CLOTTING FACTOR 8; PROTHROMBIN;

ADULT; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NEUROPIL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VASCULAR AMYLOIDOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BASEMENT MEMBRANE; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; CEREBROVASCULAR DISORDERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH; POSTMORTEM CHANGES; PROTHROMBIN;

EID: 34247343262     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.05.016     Document Type: Article

References (64)

1. Akiyama H., Ikeda K., Kondo H., and McGeer P.L. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 146 (1992) 152-154
2. Alafuzoff I., Adolfsson R., Bucht G., and Winblad B. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J Neurol Sci 60 (1983) 465-472
3. Aliev G., Seyidova D., Lamb B.T., Obrenovich M.E., Siedlak S.L., Vinters H.V., et al. Mitochondrial and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res 25 September (6) (2003) 665-674
4. Arai T., Miklossy J., Klegeris A., Guo J.P., and McGeer P.L. Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol 65 January (1) (2006) 19-25
5. Aronson M.K., Ooi W.L., Morgenstern H., Hafner A., Masur D., Crystal H., et al. Women, myocardial infarction, and dementia in the very old. Neurology 40 (1990) 1102-1106
6. Attems J., and Jellinger K.A. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol (Berl.) 107 (2004) 83-90
7. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., et al. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 21 (2000) 349-355
8. Blennow K., Wallin A., Fredman P., Karlsson I., Gottfries C.G., and Svennerholm L. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand 81 (1990) 323-326
9. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl.) 82 (1991) 239-259
10. Breteler M.M. Vascular involvement in cognitive decline and dementia Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci 903 (2000) 457-465
11. Buee L., Hof P.R., and Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann N Y Acad Sci 826 (1997) 7-24
12. Cacciatore F., Abete P., Ferrara N., Paolisso G., Amato L., Canonico S., et al. The role of blood pressure in cognitive impairment in an elderly population Osservatorio Geriatrico Campano Group. J Hypertens 15 (1997) 135-142
13. Corder E., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
14. Davies D.C., and Hardy J.A. Blood brain barrier in ageing and Alzheimer's disease. Neurobiol Aging 9 (1988) 46-48
15. DeKosky S.T., Shih W.J., Schmitt F.A., Coupal J., and Kirkpatrick C. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Dis Assoc Disord 4 (1990) 14-23
16. Deschepper C.F., Bigornia V., Berens M.E., and Lapointe M.L. Production of thrombin and antithrombin III by rat brain astroglial cell cultures. Mol Brain Res 11 (1991) 355-358
17. Dihanich M., Kaser M., Reinhard E., Cunningham D., and Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6 (1991) 575-581
18. Doddy R.S., Massman P.J., Mawad M., and Nance M. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol 11 (1998) 191-199
19. Donahue J.E., Berzin T.M., Rafii M.S., Glass D.J., Yancopoulos G.D., Fallon J.R., et al. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc Natl Acad Sci USA 96 (1999) 6468-6472
20. Eberling J.L., Jagust W.J., Reed B.R., and Baker M.G. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 2000 13 (1992) 483-491
21. Frolich L., Kornhuber J., Ihl R., Fritze J., Maurer K., and Riederer P. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur Arch Psychiatry Clin Neurosci 240 (1991) 363-366
22. Fujii K., Sadoshima S., Okada Y., Yao H., Kuwabara Y., Ichiya Y., et al. Cerebral blood flow and metabolism in normotensive and hypertensive patients with transient neurologic deficits. Stroke 21 (1990) 283-290
23. Fullerton S.M., Shirman G.A., Strittmatter W.J., and Matthew W.D. Impairment of the blood-nerve and blood-brain barriers in Apolipoprotein E knockout mice. Exp Neurol 169 (2001) 13-22
24. Graves A., van Duijn C.M., Chandra V., et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies EURODEM Risk Factors Research Group. Int J Epidemiol 20 (1991) S48-S57
25. Hamos J.E., DeGennaro L.J., and Drachman D.A. Synaptic loss in Alzheimer's disease and other dementias. Neurology 39 3 (1989) 355-361
26. Hampel H., Muller-Spahn F., Berger C., Haberl A., Ackenheil M., and Hock C. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation. Dementia 6 (1995) 348-354
27. Hofman A., Ott A., Breteler M.M., Bots M.L., Slooter A.J., van Harskamp F., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349 (1997) 151-154
28. Huda W., and Slone R. Comparative resolution limits of diagnostic imaging techniques. Review of radiation physics (2002), Lippincott, Williams and Wilkins 1995
29. Inoue S. Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease. Int Rev Cytol 210 (2001) 121-161
30. Kalaria R.N., and Grahovac I. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res 516 (1990) 349-353
31. Kalaria R.N., Golde T.E., Cohen M.L., and Younkin S.G. Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier. Ann N Y Acad Sci 640 (1991) 145-148
32. Kalaria R.N., and Perry G. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease. Brain Res 631 (1993) 151-155
33. Kalaria R.N., and Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13 3 Suppl (1999) S115-S123
34. Kawai M., Kalaria R.N., Harik S.I., and Perry G. The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137 (1990) 1435-1446
35. Kay A.D., May C., Papadopoulos N.M., Costello R., Atack J.R., Luxenberg J.S., et al. CSF and serum concentrations of albumin and IgG in Alzheimer's disease. Neurobiol Aging 2000 8 (1987) 21-25
36. Kimura M., Arai H., Takahashi T., and Iwamoto N. Amyloid-P-component-like immunoreactivity in beta/A4-immunoreactive deposits in Alzheimer-type dementia brains. J Neurol 241 (1994) 170-174
37. Leonardi A., Gandolfo C., Caponnetto C., Arata L., and Vecchia R. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J Neurol Sci 67 (1985) 253-261
38. Lewczuk P., Wiltfang J., Lange M., Jahn H., Reiber H., and Ehrenreich H. Prothrombin concentration in the cerebrospinal fluid is not altered in Alzheimer's Disease. Neurochem Res 24 (1999) 1531-1534
39. Martin L.J., Pardo C.A., Cork L.C., and Price D.L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 145 (1994) 1358-1381
40. Mecocci P., Parnetti L., Reboldi G.P., Santucci C., Gaiti A., Ferri C., et al. Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias. Acta Neurol Scand 84 (1991) 210-213
41. Miyakawa T., Shikai I., Shimoji A., Kuramoto R., and Nagatoshi K. Electron-microscopical study on senile plaques in Alzheimer's disease. Folia Psychiatr Neurol Jpn 33 (1979) 197-203
42. Miyakawa T., Shimoji A., Kuramoto R., and Higuchi Y. The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol 40 (1982) 121-129
43. Mulder M., Blokland A., van den Berg D.J., Schulten H., Bakker A.H., Terwel D., et al. Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab Invest 81 (2001) 953-960
44. Nakane H., Ibayashi S., Fujii K., Irie K., Sadoshima S., and Fujishima M. Cerebral blood flow and metabolism in hypertensive patients with cerebral infarction. Angiology 46 (1995) 801-810
45. Nobili F., Rodriguez G., Marenco S., De Carli F., Gambaro M., Castello C., et al. Regional cerebral blood flow in chronic hypertension A correlative study. Stroke 24 (1993) 1148-1153
46. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and Breteler M.M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53 (1999) 1937-1942
47. Perlmutter L.S., Barron E., Myers M., Saperia D., and Chui H.C. Localization of amyloid P component in human brain: vascular staining patterns and association with Alzheimer's disease lesions. J Comp Neurol 352 (1995) 92-105
48. Petito C.K., and Cash K.S. Blood-brain-barrier abnormalities in acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32 (1992) 658-666
49. Pompili E., Nori S.L., Geloso M.C., Guadagni E., Corvino V., Michetti F., et al. Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Brain Res Mol Brain Res 122 March (1) (2004) 93-98
50. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34 (1993) 339-350
51. Rhodes R.H. Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 50 (1991) 171-183
52. Roses A.D. The Alzheimer diseases. Curr Opin Neurobiol 6 (1996) 644-650
53. Salloway S., Gur T., Berzin T., Tavares R., Zipser B., Correia S., et al. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. J Neurol Sci. 203-204 November (15) (2002) 183-187
54. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
55. Scheltens P., Barkhof F., Valk J., Algra P.R., van der Hoop R.G., Nauta J., et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain Res 115 (1992) 735-748
56. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., et al. 15-year longitudinal study of blood pressure and dementia. Lancet (1996) 1141-1145
57. Skoog I., Wallin A., Fredman P., Hesse C., Aevarsson O., Karlsson I., et al. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 50 (1998) 966-971
58. Slooter A.J., Tang M.X., van Duijn C.M., et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke A population-based investigation. JAMA 277 (1997) 818-821
59. Stewart P.A., Hayakawa K., Akers M.A., and Vinters H.V. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67 6 Dec (1992) 734-742
60. Thal D.R., Ghebremedhin E., Rub U., Yamaguchi H., Tredici K.D., and Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61 (2002) 282-293
61. Trojanowski J.Q., Clark C.M., Schmidt M.L., Arnold S.E., and Lee V.M. Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease. Neurobiol Aging 18 (1997) S75-S79
62. Wada H. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Intern Med 37 (1998) 509-513
63. Weisgraber K.H., Roses A.D., and Strittmatter W.J. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 5 (1994) 110-116
64. Vonsattel J.P., Myers R.H., Hedley-Whyte E.T., Ropper A.H., Bird E.D., and Richardson E.P. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30 5 (1991) 637-649